Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NI-0401 in Moderate to Severe Active Crohn's Disease
NCT00630643Phase 2Completed
- Sponsor
- Lightchain Bioscience
- Start
- Jan 2006
- Primary completion
- Dec 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of foralumab in Crohn's disease, sponsored by Lightchain Bioscience. Started Jan 2006; status: completed.
02
Drugs
foralumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00630643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630643.